Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jan Potempa

Showing results (41-50 of 354) with videos related to

Pageof 36
Sort By:
Molecular Microbiology|July 28, 2005
Fighting an enemy within: cytoplasmic inhibitors of bacterial cysteine proteasesJan Potempa, Ewa Golonka, Renata Filipek, et al.
Biological Chemistry|December 4, 2004
Coordinate expression of the Porphyromonas gingivalis lysine-specific gingipain proteinase, Kgp, arginine-specific gingipain proteinase, RgpA, and the heme/hemoglobin receptor, HmuRXinyan Liu, Aneta Sroka, Jan Potempa, et al.
FEMS Immunology and Medical Microbiology|January 22, 2008
Staphylococcus aureus infection triggers production of neutralizing, V8 protease-specific antibodiesAnn-Marie Calander, Grzegorz Dubin, Jan Potempa, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 22, 2007
Biphasic effect of gingipains from Porphyromonas gingivalis on the human complement systemKatarzyna Popadiak, Jan Potempa, Kristian Riesbeck, et al.
Biochimie|September 27, 2015
Kallikreins - The melting pot of activity and functionMagdalena Kalinska, Ulf Meyer-Hoffert, Tomasz Kantyka, et al.
Biochemistry|November 3, 2004
Prostaphopain B structure: a comparison of proregion-mediated and staphostatin-mediated protease inhibitionRenata Filipek, Roman Szczepanowski, Artur Sabat, et al.
Advances in Experimental Medicine and Biology|June 11, 2011
The lysine-specific gingipain of Porphyromonas gingivalis : importance to pathogenicity and potential strategies for inhibitionTang Yongqing, Jan Potempa, Robert N Pike, et al.
The Journal of Biological Chemistry|December 2, 2006
Thrombin-activable fibrinolysis inhibitor (TAFI) zymogen is an active carboxypeptidaseZuzana Valnickova, Ida B Thøgersen, Jan Potempa, et al.
Periodontology 2000|December 19, 2009
Complementary Tolls in the periodontium: how periodontal bacteria modify complement and Toll-like receptor responses to prevail in the hostJennifer L Krauss, Jan Potempa, John D Lambris, et al.
Orphanet Journal of Rare Diseases|January 29, 2016
Gingival fibromatosis: clinical, molecular and therapeutic issuesKatarzyna Gawron, Katarzyna Łazarz-Bartyzel, Jan Potempa, et al.
Pageof 36

Showing results (41-50 of 354) with videos related to

Sort By:
Pageof 36
Molecular Microbiology|July 28, 2005
Fighting an enemy within: cytoplasmic inhibitors of bacterial cysteine proteasesJan Potempa, Ewa Golonka, Renata Filipek, et al.
Biological Chemistry|December 4, 2004
Coordinate expression of the Porphyromonas gingivalis lysine-specific gingipain proteinase, Kgp, arginine-specific gingipain proteinase, RgpA, and the heme/hemoglobin receptor, HmuRXinyan Liu, Aneta Sroka, Jan Potempa, et al.
FEMS Immunology and Medical Microbiology|January 22, 2008
Staphylococcus aureus infection triggers production of neutralizing, V8 protease-specific antibodiesAnn-Marie Calander, Grzegorz Dubin, Jan Potempa, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 22, 2007
Biphasic effect of gingipains from Porphyromonas gingivalis on the human complement systemKatarzyna Popadiak, Jan Potempa, Kristian Riesbeck, et al.
Biochimie|September 27, 2015
Kallikreins - The melting pot of activity and functionMagdalena Kalinska, Ulf Meyer-Hoffert, Tomasz Kantyka, et al.
Biochemistry|November 3, 2004
Prostaphopain B structure: a comparison of proregion-mediated and staphostatin-mediated protease inhibitionRenata Filipek, Roman Szczepanowski, Artur Sabat, et al.
Advances in Experimental Medicine and Biology|June 11, 2011
The lysine-specific gingipain of Porphyromonas gingivalis : importance to pathogenicity and potential strategies for inhibitionTang Yongqing, Jan Potempa, Robert N Pike, et al.
The Journal of Biological Chemistry|December 2, 2006
Thrombin-activable fibrinolysis inhibitor (TAFI) zymogen is an active carboxypeptidaseZuzana Valnickova, Ida B Thøgersen, Jan Potempa, et al.
Periodontology 2000|December 19, 2009
Complementary Tolls in the periodontium: how periodontal bacteria modify complement and Toll-like receptor responses to prevail in the hostJennifer L Krauss, Jan Potempa, John D Lambris, et al.
Orphanet Journal of Rare Diseases|January 29, 2016
Gingival fibromatosis: clinical, molecular and therapeutic issuesKatarzyna Gawron, Katarzyna Łazarz-Bartyzel, Jan Potempa, et al.
Pageof 36